Login

Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore 00:10:00

Share On Facebook Share On Twitter

Babak Bemani is a CEO & Founder of Bit Azin and Drillmore Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
FTC Solar defines its essence and purpose through its identity and mission | SEAN HUNKLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, FTC SOLAR INC
00:10:00
Mark Mobius on the Future of Emerging Markets and Investment Opportunities
00:10:00
SiTime CEO Rajesh Vashist joins Jill Malandrino on Nasdaq #TradeTalks to discuss the precision timing category and its impact.
00:10:00
Reporting Season February 2020: Beach Energy | Morné Engelbrecht, CEO, Beach Energy LtdBPT:ASX
00:10:00
Silver One Resources: Candelaria Project Overview and Recent Developments
00:10:00
The Challenge of Cybercrime and Intangible Assets in a Borderless Digital World
00:10:00
Lucara Diamond Corporation: Innovation, Sustainability, and Exceptional Diamond Recovery
00:10:00
Technology's Impact on Education: Transforming Learning and Resisting Change|Terry M. Moe
00:10:00
Norway: Leading the Charge Towards Electric Vehicle Adoption|Ragnhild Syrstad,State Secretary,Norway
00:10:00
Investment manager whose investment philosophy was inspired by the original 1950’s Buffett partnerships|GUY SPIER, Managing Partner,Aquamarine Fund
00:10:00
AI and Beyond: The Future of Munro Global Growth Funds | Nick Griffin, Founder and CIO, Munro Partners
00:10:00
With a Collaborative Approach and Diverse Capabilities JLL Extends Partnership Far Beyond Capital|DAN AGROSKIN,Managing Director,JLL Partners

© 2017 - Neuhu+